Oncology & Cancer

Targeted treatment for leukemia approved on NHS in England 

The targeted drug gilteritinib is now recommended for some adults with acute myeloid leukemia (AML) on the NHS in England. The National Institute for Health and Care Excellence (NICE) overturned their initial rejection of ...

Neuroscience

How to navigate epilepsy care

Despite the development of several new anti-seizure medications or anti-epileptic drugs over the past couple of decades, approximately 30 to 40% of epilepsy patients remain refractory—or resistant to medical treatment. ...

Oncology & Cancer

Clinical trial shows promising new treatment for rare blood cancer

Lymphoma is a type of blood cancer that develops from lymphocytes (a type of white blood cell). It has many subtypes. A rare subtype, called intravascular large B-cell lymphoma (or IVLBCL) is notably hard to diagnose accurately ...

Oncology & Cancer

Exercise works for those beginning cancer treatment

Associate Professor Anthony Leicht was part of an international group led by Professor John Saxton from Northumbria University and the University of East Anglia that studied how exercise might help prostate cancer sufferers ...

page 16 from 26